Healthcare Brands International (HBI) (United Kingdom) - Dec 2007

Healthcare Brands International (HBI), a medical product commercialisation business backed by a consortium of venture players, has acquired Antula Holdings AB, a privately-owned Scandanavian over-the-counter (OTC) business, and its subsidiaries. The acquisition represents an important milestone in HBI’s goal of building an international OTC healthcare business and is its third to date. The deal was funded by new capital provided by new investors Essex Woodlands with all other existing investors – Abingworth, MVM Life Sciences, Goldman Sachs, Sofinnova Partners and 3i – also participating in the transaction. The existing investors provided start-up HBI with £25m of funding in 2006 (23 October 2006, page 22). The investors together hold a majority stake in the company.

Company

HBI will specialise in commercialising currently unexploited OTC brands, targeting companies which have successfully developed innovative technology, but lack the commercial capability and resources to realise their potential. HBI will focus on consumer needs that are currently either unmet or partially met by available OTC products. It will focus turning medical products into consumer brands. These will be products underpinned with strong clinical data to build the brand. HBI is based in Nottingham.

People

Barry Clare is the chairman and CEO of HBI.

Sourced from: UK & Ireland unquote" 361 (Jan 2008)

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Expansion
• Healthcare
• United Kingdom